These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37800552)

  • 1. Comment on 'The role of aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis after total knee arthroplasty: a meta-analysis of randomized controlled trials'.
    Guo X; Zheng S; Zhi Y
    Int J Surg; 2024 Jan; 110(1):621-622. PubMed ID: 37800552
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness of low-molecular-weight heparin compared with aspirin for prophylaxis against venous thromboembolism after total joint arthroplasty.
    Schousboe JT; Brown GA
    J Bone Joint Surg Am; 2013 Jul; 95(14):1256-64. PubMed ID: 23864173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-Molecular-Weight Heparin and the Relative Risk of Surgical Site Bleeding Complications: Results of a Systematic Review and Meta-Analysis of Randomized Controlled Trials of Venous Thromboprophylaxis in Patients After Total Joint Arthroplasty.
    Suen K; Westh RN; Churilov L; Hardidge AJ
    J Arthroplasty; 2017 Sep; 32(9):2911-2919.e6. PubMed ID: 28522244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and effectiveness of aspirin and enoxaparin for venous thromboembolism prophylaxis after total hip and knee arthroplasty: a systematic review.
    Nadi S; Vreugdenburg TD; Atukorale Y; Ma N; Maddern G; Rovers M
    ANZ J Surg; 2019 Oct; 89(10):1204-1210. PubMed ID: 30989803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis after total knee arthroplasty: a meta-analysis of randomized controlled trials.
    Meng J; Liu W; Xiao Y; Tang H; Wu Y; Gao S
    Int J Surg; 2023 Nov; 109(11):3648-3655. PubMed ID: 37578443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Primary Hip and Knee Arthroplasty as Reported by American Board of Orthopedic Surgery Part II Candidates.
    Runner RP; Gottschalk MB; Staley CA; Pour AE; Roberson JR
    J Arthroplasty; 2019 Apr; 34(4):729-734. PubMed ID: 30685257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISTAL: protocol for a cluster randomised, crossover, non-inferiority trial of aspirin compared to low molecular weight heparin for venous thromboembolism prophylaxis in hip or knee arthroplasty, a registry nested study.
    Sidhu VS; Graves SE; Buchbinder R; Naylor JM; Pratt NL; de Steiger RS; Chong BH; Ackerman IN; Adie S; Harris A; Hansen A; Cripps M; Lorimer M; Webb S; Clavisi O; Griffith EC; Anandan D; O'Donohue G; Kelly TL; Harris IA
    BMJ Open; 2019 Nov; 9(11):e031657. PubMed ID: 31699735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
    Matharu GS; Kunutsor SK; Judge A; Blom AW; Whitehouse MR
    JAMA Intern Med; 2020 Mar; 180(3):376-384. PubMed ID: 32011647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Effectiveness and Safety of Drug Prophylaxis for Prevention of Venous Thromboembolism After Total Knee Arthroplasty.
    Cafri G; Paxton EW; Chen Y; Cheetham CT; Gould MK; Sluggett J; Bini SA; Khatod M
    J Arthroplasty; 2017 Nov; 32(11):3524-3528.e1. PubMed ID: 28634095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin versus enoxaparin for the initial prevention of venous thromboembolism following elective arthroplasty of the hip or knee: A systematic review and meta-analysis.
    Farey JE; An VVG; Sidhu V; Karunaratne S; Harris IA
    Orthop Traumatol Surg Res; 2021 Feb; 107(1):102606. PubMed ID: 32631716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staged venous thromboemolic events prophylaxis with low-molecular-weight heparin followed by aspirin is safe and effective after arthroplasty.
    Asopa V; Cobain W; Martin D; Keene G; Bauze A
    ANZ J Surg; 2015 Sep; 85(9):652-7. PubMed ID: 25997601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy and safety of aspirin in prevention of venous thromboembolism after total joint arthroplasty].
    Tian H; Song F; Zhang K; Liu Y
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(47):3349-52. PubMed ID: 18478950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous Thromboembolism Chemoprophylaxis in Total Hip and Knee Arthroplasty: A Critical Analysis Review.
    Trivedi NN; Fitzgerald SJ; Schmaier AH; Wera GD
    JBJS Rev; 2019 Jan; 7(1):e2. PubMed ID: 30601202
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of pharmacologic prophylaxis in prevention of venous thromboembolism following total knee arthroplasty.
    Richardson SS; Schairer WW; Sculco PK; Bostrom MP
    Knee; 2019 Mar; 26(2):451-458. PubMed ID: 30700390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after knee replacement: a non-randomised comparison using National Joint Registry Data.
    Jameson SS; Baker PN; Charman SC; Deehan DJ; Reed MR; Gregg PJ; Van der Meulen JH
    J Bone Joint Surg Br; 2012 Jul; 94(7):914-8. PubMed ID: 22733945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No Increased Risk of Venous Thromboembolism in High-Risk Patients Continuing Their Dose of 75 mg Aspirin Compared to Healthier Patients Given Low-Molecular-Weight Heparin.
    Hovik O; Amlie EJ; Jenssen KK
    J Arthroplasty; 2021 Oct; 36(10):3589-3592. PubMed ID: 34176693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of venous thromboembolism after total joint arthroplasty: aspirin is enough for most patients.
    Dalury D; Lonner J; Parvizi J
    Am J Orthop (Belle Mead NJ); 2015 Feb; 44(2):59-60. PubMed ID: 25658072
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis.
    Neumann I; Rada G; Claro JC; Carrasco-Labra A; Thorlund K; Akl EA; Bates SM; Guyatt GH
    Ann Intern Med; 2012 May; 156(10):710-9. PubMed ID: 22412038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review of aspirin for thromboprophylaxis in modern elective total hip and knee arthroplasty.
    Wilson DG; Poole WE; Chauhan SK; Rogers BA
    Bone Joint J; 2016 Aug; 98-B(8):1056-61. PubMed ID: 27482017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thromboembolism debate in joint arthroplasty.
    Lieberman JR; Barnes CL; Lachiewicz PF; Hanssen AD; Clarke HD; Pellegrini VD
    J Bone Joint Surg Am; 2009 Aug; 91 Suppl 5():29-32. PubMed ID: 19648620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.